AlloMap is one type of non-invasive diagnostic test that may be used to identify patients who have a low probability of moderate/severe acute cellular rejection at the time of testing.

What does an AlloMap test?

AlloMap is one type of non-invasive diagnostic test that may be used to identify patients who have a low probability of moderate/severe acute cellular rejection at the time of testing.

Is AlloMap covered by Medicare?

*Under FDA-cleared labeling, AlloMap is indicated for use in heart transplant patients who are ≥15 years old and ≥55 days post transplant. AlloSure Heart is covered by Medicare after 55 days when ordered in conjunction with AlloMap and with clinical suspicion of rejection.

What is AlloMap and AlloSure?

– AlloMap (gene expression test) detects immune activation and is. clinically validated for ACR monitoring. – AlloSure (cfDNA assay) detects graft injury and is validated for ACR and. AMR monitoring.

What is a normal AlloMap score?

The AlloMap test has a high NPV, ranging from ∼98 to 99%, for scores considered as appropriate clinical threshold values in each of the three time periods post-transplant (Deng et al., 2006b).

What is a good AlloMap score?

A lower score indicates a lower risk of graft rejection. AlloMap Test Results: Low risk threshold score Month 2-6: 30 Score < threshold: No biopsy Month 6-12: 34 Score ≥ threshold: Biopsy within 5 days of result (>34) Month 12+: 34 Score ≥ threshold, after 3 prior scores ≥ 34 1.

What is the CPT code for AlloMap?

To bill for AlloMap services, please provide the following claim information: For claims prior to 01/01/2016: CPT® code 81479 – Unlisted immunology procedure (NOC)

How does AlloSure?

The AlloSure test is a clinical-grade, targeted, next generation sequencing (NGS) assay that measures single-nucleotide polymorphisms (SNPs) to accurately quantify donor-derived cell-free DNA (dd-cfDNA) in renal transplant recipients without separate genotyping of either the donor or the recipient.

How long does it take to get AlloMap results?

The mean and median AlloMap scores in the general heart transplant recipient cohorts from the OAR study and from the database of all commercially ordered AlloMaps, rise most sharply from 2 to 6 months post-transplant, and more gradually beween 7 to 12 months post-transplant.

What is the CPT code for a diagnostic amniocentesis?

59000
CPT® Code 59000 in section: Amniocentesis.

How do you read AlloSure test results?

The current AlloSure result is shown as the percent of donor- derived cell-free DNA (dd-cfDNA) in the total cell-free DNA (cfDNA) in the results box and plotted on the graph along with the numerical value. Results less than 0.12%* (less than 0.18%* for closely related donors) are plotted near the bottom of the graph.

Is AlloSure a blood test?

AlloSure helps your doctor monitor the health of your new kidney. This simple blood test is more accurate than traditional tests like serum creatinine. AlloSure measures a biomarker in your blood called donor-derived cell-free DNA (dd-cfDNA).

Is amniocentesis a genetic test?

Amniocentesis is a prenatal test that can diagnose genetic disorders (such as Down syndrome and spina bifida) and other health issues in an unborn baby. A provider uses a needle to remove a small amount of amniotic fluid from inside your uterus, and then a lab tests the sample for specific conditions.